[HTML][HTML] 分子靶向治疗在肺鳞癌中的研究进展
马丽， 张树才 - Chinese Journal of Lung Cancer, 2013 - ncbi.nlm.nih.gov
… of lung cancer worldwide, about 400, 000 persons die from squamous-cell lung cancer around
… Unfortunately, squamous-cell lung cancer patients do not benefit from major advances in …
… Unfortunately, squamous-cell lung cancer patients do not benefit from major advances in …
[PDF][PDF] 三阴性乳腺癌免疫治疗进展
韩佳澍， 谢霄鹤， 吴孟闱， 马飞 - 肿瘤, 2022 - tumorsci.org
… treatment of patients with advanced non small cell lung cancer[… Lenvatinib plus pembrolizumab
or everolimus for advanced … /paclitaxel or cap ecitabine and atezolizumab in patients with …
or everolimus for advanced … /paclitaxel or cap ecitabine and atezolizumab in patients with …
乳腺癌靶向治疗新进展.
赵晶， 吴楠， 张世超， 赵紫薇… - Chinese Journal of …, 2020 - search.ebscohost.com
… Combination of everolimus with trastuzumab plus paclitaxel as first⁃line treatment for … of
durvalumab plus tremelimumab in non⁃small cell lung cancer: a multicentre, phase 1b study[J]. …
durvalumab plus tremelimumab in non⁃small cell lung cancer: a multicentre, phase 1b study[J]. …